- JP-listed companies
- Income statement
(4932) Income statement
Market cap
¥6.5B
P/E ratio
11.1x
Almado develops health and beauty products using eggshell membrane biotechnology, selling cosmetics and supplements through TV shopping and e-commerce.
| 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Revenue | 2,135 | 1,956 | 2,754 | 3,789 | 5,796 | 4,548 | 5,365 | 6,529 | 7,539 | 8,477 | 10,119 |
| Revenue growth (%) | - | ||||||||||
| Cost of revenue | - | - | - | 1,644 | 2,186 | 1,744 | 2,044 | 2,179 | 2,468 | 2,553 | 2,495 |
| Gross profit | - | - | - | 2,145 | 3,610 | 2,804 | 3,321 | 4,350 | 5,071 | 5,925 | 7,624 |
| Gross margin (%) | - | - | - | ||||||||
| Operating margin (%) | - | - | - | ||||||||
| Operating expenses | - | - | - | 1,685 | 2,625 | 2,277 | 2,485 | 3,518 | 4,111 | 4,978 | 6,939 |
| Operating income | - | - | - | 459 | 985 | 527 | 836 | 832 | 961 | 946 | 685 |
| Income before tax | -20 | 138 | 563 | 457 | 983 | 537 | 837 | 837 | 963 | 937 | 690 |
| Pretax margin (%) | -0.9 | 7.1 | 20.4 | 12.1 | 17 | 11.8 | 15.6 | 12.8 | 12.8 | 11 | 6.8 |
| Provision for income taxes | - | - | - | 124 | 331 | 169 | 254 | 251 | 268 | 286 | 171 |
| Effective tax rate (%) | - | - | - | ||||||||
| Net income | -18 | 101 | 205 | 334 | 652 | 368 | 582 | 586 | 695 | 650 | 518 |
| Earnings per share | -23,796.68 | 134,183.61 | 233,690.04 | 33.27 | 64.97 | 36.69 | 57.81 | 60.29 | 72.98 | 70.43 | 56.07 |
| Diluted EPS | - | - | - | - | - | - | 57.55 | 60.22 | 72.89 | 70.43 | - |
| Dividend payout ratio (%) | - | - | - | - | - | - | - | ||||
| Dividend per share | - | - | - | - | - | - | 40 | 65 | 70 | 65 | 42 |